Skip to content
Home/Research/AOD-9604

AOD-9604 Research & Studies

We track 16 published, PubMed-indexed studies for AOD-9604, spanning 2001 to 2026. The research below includes 5 reviews, 10 research articles, 1 clinical trial.

These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
5
Reviews
10
Research Articles
1
Clinical Trial

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Review
Rahman OF, Lee SJ, Seeds WA|J Am Acad Orthop Surg Glob Res Rev|2026

Human sports drug testing by mass spectrometry.

Review
Schänzer W, Thevis M|Mass Spectrom Rev|2017

Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

Research Article
Thomas A, Görgens C, et al.|J Sep Sci|2016

Detection and in vitro metabolism of AOD9604.

Research Article
Cox HD, Smeal SJ, et al.|Drug Test Anal|2015

Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.

Research Article
Kwon DR, Park GY|Ann Clin Lab Sci|2015

Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.

Review
Thevis M, Schänzer W|J Pharm Biomed Anal|2014

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.

Research Article
Thevis M, Thomas A, Schänzer W|Expert Rev Proteomics|2014

Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.

Research Article
Vanhee C, Moens G, et al.|Drug Test Anal|2014

AOD-9604 does not influence the WADA hGH isoform immunoassay.

Research Article
Orlovius AK, Thomas A, et al.|Drug Test Anal|2013

Metabolic Pharmaceuticals Phase 2b/3 trial of AOD-9604 for obesity: failed to show significant weight loss vs placebo (2007, Australia). Development discontinued.

Clinical Trial
Metabolic Pharmaceuticals Ltd|Company Press Release / Clinical Trial Report|2007

Obesity drugs in clinical development.

Review
Halford JC|Curr Opin Investig Drugs|2006

Gateways to clinical trials.

Research Article
Bayés M, Rabasseda X, Prous JR|Methods Find Exp Clin Pharmacol|2005

AOD-9604 Metabolic.

Review
Wilding J|Curr Opin Investig Drugs|2004

Gateways to clinical trials.

Research Article
Bayes M, Rabasseda X, Prous JR|Methods Find Exp Clin Pharmacol|2003

Gateways to clinical trials.

Research Article
Bayés M, Rabasseda X, Prous JR|Methods Find Exp Clin Pharmacol|2003

The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.

Research Article
Heffernan M, Summers RJ, et al.|Endocrinology|2001